Karp Capital Management’s Exact Sciences EXAS Stock Holding History

Karp Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-600	Closed	-$38K	–	199
2018 Q4	$38K	Buy	+600	New	+$41.2K	0.02%	162

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Karp Capital Management's EXAS Position: Q1 2019 in Review

Karp Capital Management sold out of Exact Sciences (EXAS) in Q1 2019, closing a stake of 600 shares — an estimated $38K sold.

Karp Capital Management first reported a position in EXAS in Q4 2018 and held it in 1 quarter. The position peaked at $38K in Q4 2018. 424 funds tracked by Wall St. Rank hold EXAS as of Q1 2019.

Karp Capital Management reported no remaining Exact Sciences position as of Q1 2019 after selling out during the quarter.
Karp Capital Management sold 600 Exact Sciences shares in Q1 2019, an estimated $38K.
Karp Capital Management first reported a position in Exact Sciences in Q4 2018 and held it in 1 quarter.
Karp Capital Management's Exact Sciences position peaked at $38K in Q4 2018.
424 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2019.

Based on Karp Capital Management's 13F filing for Q1 2019, filed 7 May 2019.